New Zealand markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
124.71-1.34 (-1.06%)
At close: 04:02PM EST
124.68 -0.03 (-0.02%)
After hours: 07:53PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
42,308,000
34,608,000
31,904,000
30,578,000
Cost of revenue
18,264,000
15,003,000
13,231,000
12,706,000
Gross profit
24,044,000
19,605,000
18,673,000
17,872,000
Operating expenses
Research development
2,678,000
2,420,000
2,440,000
2,300,000
Selling general and administrative
10,846,000
9,696,000
9,765,000
9,744,000
Total operating expenses
15,565,000
14,248,000
14,141,000
14,222,000
Operating income or loss
8,479,000
5,357,000
4,532,000
3,650,000
Interest expense
538,000
546,000
670,000
826,000
Total other income/expenses net
290,000
111,000
121,000
-56,000
Income before tax
8,272,000
4,968,000
4,077,000
2,873,000
Income tax expense
1,032,000
497,000
390,000
539,000
Income from continuing operations
7,240,000
4,471,000
3,687,000
2,334,000
Net income
7,244,000
4,495,000
3,687,000
2,368,000
Net income available to common shareholders
7,244,000
4,495,000
3,687,000
2,368,000
Basic EPS
-
2.54
2.09
1.35
Diluted EPS
-
2.50
2.06
1.33
Basic average shares
-
1,771,230
1,762,503
1,755,619
Diluted average shares
-
1,786,000
1,781,000
1,770,000
EBITDA
-
8,841,000
7,761,000
6,977,000